Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

Clinical trial NCT06856499 · RECRUITING

Trial details

NCT number: NCT06856499
Sponsor: University of Colorado, Denver
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Endometrioid Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer

Start date: 2025-12-08
Primary completion: 2029-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.